CERS Margin dodolan resik Cerus Corporation

Logo perusahaan publik Cerus Corp (CERS)

The foundation of the Cerus Corporation (CERS) analysis is its status as the global benchmark for blood safety thanks to the INTERCEPT system. Actual net profit margins visualize cost management efficiency, where the -3.20 mark reflects the latest data. Stable cash flow is driven by the sale of disposable consumables, while production flexibility is maintained through a network of certified external partners, eliminating supplier dependency.

Rentabilitas dodolan resik cerus.com (CERS): kanggo periode 04.07.2022 - 20.11.2026

Ringkesan rincian data analitis Cerus Corp (CERS)

- nilai pasar lan prakiraan target analis:
Analisis dhasar perusahaan:Cerus Inc - CERS
Produk asil prodhuksi Cerus Corp.

Recurring sales of blood sterilization consumables provide Cerus Corporation (CERS) with high cash flow predictability. This metric reflects the portion of net profit in every dollar of revenue after deducting all operating and tax expenses; therefore, the consolidated net profit margin serves as an indicator of cost management efficiency and the primary guarantor of the sustainability of future dividend payments.

Analisis perusahaan pesaing

Intuitive Surgical, Inc. (ISRG) - Margin resik|Margin resik Danaher Corporation (DHR)|Margin resik Becton Dickinson & Co|Rentabilitas dodolan resik STE (STERIS plc)|Rentabilitas dodolan miturut bathi resik WST (West Pharmaceutical Services Inc)|Rentabilitas resik perusahaan BAX|Masimo Corporation - Rentabilitas dodolan miturut bathi resik|Rentabilitas resik perusahaan STVN (Stevanato Group SpA)|TFX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Merit Medical Corp MMSI|NVST: Margin dodolan resik|ICUI - Margin dodolan perusahaan|XRAY (Sirona Dental Systems) - Margin dodolan resik|Margin resik LeMaitre Vascular Inc LMAT|Margin resik AtriCure Corp (ATRC)|Margin dodolan resik STAAR Surgical Corp (STAA)|Margin resik niagenbioscience.com NAGE|ZimVie Inc. - Margin resik|ANGO - Margin resik|TKNO - Margin dodolan resik|Monogram Technologies Inc (MGRM) - Margin resik|STSS - Margin dodolan perusahaan|Margin resik InfuSystem Holdings, Inc.|Margin resik Utah Medical Products UTMD|Margin dodolan resik KRMD|Margin dodolan perusahaan Nyxoah, S.A.|Microbot Medical Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Pro-Dex Inc. (PDEX)|Zentek - Margin dodolan resik|Elutia (ELUT) - Rentabilitas dodolan miturut bathi resik|Milestone Scientific Inc (MLSS) - Margin resik|NXGL - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RVP|Harvard Bioscience, Inc. (HBIO) - Margin dodolan perusahaan|Margin dodolan resik FEMY|Margin dodolan resik Meihua Medical Technologies (MHUA)|Margin dodolan resik POAI (Predictive Oncology)|CJMB - Rentabilitas dodolan miturut bathi resik|ATRI: Rentabilitas dodolan miturut bathi resik|NeuroMetrix, Inc. (NURO) - Rentabilitas dodolan miturut bathi resik